OPKO Health, Inc. Finance Lease, Liability, to be Paid, Year One
OPKO Health, Inc. (OPK) had Finance Lease, Liability, to be Paid, Year One of $1.12 million as of 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-28
- 2026-06-30: Finance Lease, Liability, to be Paid, Year One $1.12M.
- 2026-03-31: Finance Lease, Liability, to be Paid, Year One $1.11M.
- 2025-12-31: Finance Lease, Liability, to be Paid, Year One $1.78M.
- 2025-09-30: Finance Lease, Liability, to be Paid, Year One $1.40M.
| Period end | Finance Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $1.12M 10-Q/A · filed 2026-08-28 |
| 2026-03-31 | $1.11M 10-Q/A · filed 2026-08-28 |
| 2025-12-31 | $1.78M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.40M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $1.40M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $1.36M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $1.81M 10-K · filed 2025-03-03 |
| 2024-09-30 | $1.81M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.55M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.50M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $3.13M 10-K · filed 2024-03-01 |
| 2023-09-30 | $3.02M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $2.74M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $2.72M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $2.92M 10-K · filed 2023-02-27 |
| 2022-09-30 | $2.50M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.43M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.05M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $2.23M 10-K · filed 2022-03-01 |
| 2021-09-30 | $1.66M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $1.65M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $1.52M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $2.53M 10-K · filed 2021-02-18 |
| 2020-09-30 | $2.24M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $2.19M 10-Q · filed 2020-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |